Company intelligence / Profile preview
S.Biomedics
South Koreasbiomedics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
S.Biomedics is a clinical-stage biotechnology company based in Korea, specializing in the development of stem-cell-derived therapies for regenerative medicine. The company announced progress at AD/PD 2025 with a one-year update on its programs. Specific clinical results are not detailed in the available sources[2].
- Therapeutic areas
- Other
- Modalities
- Stem cell therapiesRegenerative medicine[2][3]
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Beyond the preview
Go deeper on S.Biomedics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S.Biomedics.